Financials (USD)
Sales 2024 * | 16.86M | Sales 2025 * | 21.11M | Capitalization | 5.41M |
---|---|---|---|---|---|
Net income 2024 * | 2M | Net income 2025 * | 5M | EV / Sales 2024 * | 0.32 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.26 x |
P/E ratio 2024 * |
8.5
x | P/E ratio 2025 * |
3.4
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.89% |
Latest transcript on Cesca Therapeutics Inc
Managers | Title | Age | Since |
---|---|---|---|
Xiao Chun Xu
CEO | Chief Executive Officer | 53 | 16-03-09 |
Jeffery Cauble
DFI | Director of Finance/CFO | 51 | 09-12-31 |
Wendy Samford
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Russell Medford
BRD | Director/Board Member | 69 | 17-02-23 |
Joseph Thomis
BRD | Director/Board Member | 78 | 17-01-09 |
Xiao Chun Xu
CEO | Chief Executive Officer | 53 | 16-03-09 |
1st Jan change | Capi. | |
---|---|---|
+7.13% | 7.91B | |
-3.15% | 4.66B | |
-9.18% | 2.84B | |
+1.11% | 2.03B | |
-26.56% | 1.12B | |
-22.71% | 759M | |
-13.49% | 755M | |
-56.85% | 682M | |
-24.66% | 671M |